273 related articles for article (PubMed ID: 21456899)
1. Fecal calprotectin is equally sensitive in Crohn's disease affecting the small bowel and colon.
Jensen MD; Kjeldsen J; Nathan T
Scand J Gastroenterol; 2011 Jun; 46(6):694-700. PubMed ID: 21456899
[TBL] [Abstract][Full Text] [Related]
2. Fecal calprotectin and S100A12 have low utility in prediction of small bowel Crohn's disease detected by wireless capsule endoscopy.
Sipponen T; Haapamäki J; Savilahti E; Alfthan H; Hämäläinen E; Rautiainen H; Koskenpato J; Nuutinen H; Färkkilä M
Scand J Gastroenterol; 2012 Jul; 47(7):778-84. PubMed ID: 22519419
[TBL] [Abstract][Full Text] [Related]
3. Fecal calprotectin: a selection tool for small bowel capsule endoscopy in suspected IBD with prior negative bi-directional endoscopy.
Koulaouzidis A; Douglas S; Rogers MA; Arnott ID; Plevris JN
Scand J Gastroenterol; 2011 May; 46(5):561-6. PubMed ID: 21269246
[TBL] [Abstract][Full Text] [Related]
4. Endoscopic Factors Influencing Fecal Calprotectin Value in Crohn's Disease.
Goutorbe F; Goutte M; Minet-Quinard R; Boucher AL; Pereira B; Bommelaer G; Buisson A
J Crohns Colitis; 2015 Dec; 9(12):1113-9. PubMed ID: 26351383
[TBL] [Abstract][Full Text] [Related]
5. Fecal calprotectin is a predictive marker of relapse in Crohn's disease involving the colon: a prospective study.
Kallel L; Ayadi I; Matri S; Fekih M; Mahmoud NB; Feki M; Karoui S; Zouari B; Boubaker J; Kaabachi N; Filali A
Eur J Gastroenterol Hepatol; 2010 Mar; 22(3):340-5. PubMed ID: 19581809
[TBL] [Abstract][Full Text] [Related]
6. Ileoscopy reduces the need for small bowel imaging in suspected Crohn's disease.
Jensen MD; Nathan T; Rafaelsen SR; Kjeldsen J
Dan Med J; 2012 Sep; 59(9):A4491. PubMed ID: 22951194
[TBL] [Abstract][Full Text] [Related]
7. Fecal Immunochemical Test Versus Fecal Calprotectin for Prediction of Mucosal Healing in Crohn's Disease.
Inokuchi T; Kato J; Hiraoka S; Takashima S; Nakarai A; Takei D; Sugihara Y; Takahara M; Kawano S; Harada K; Okada H
Inflamm Bowel Dis; 2016 May; 22(5):1078-85. PubMed ID: 26891256
[TBL] [Abstract][Full Text] [Related]
8. Neopterin is a novel reliable fecal marker as accurate as calprotectin for predicting endoscopic disease activity in patients with inflammatory bowel diseases.
Nancey S; Boschetti G; Moussata D; Cotte E; Peyras J; Cuerq C; Haybrard J; Charlois AL; Mialon A; Chauvenet M; Stroeymeyt K; Kaiserlian D; Drai J; Flourié B
Inflamm Bowel Dis; 2013 Apr; 19(5):1043-52. PubMed ID: 23511035
[TBL] [Abstract][Full Text] [Related]
9. Prediction of Crohn's disease relapse with faecal calprotectin in infliximab responders: a prospective study.
Laharie D; Mesli S; El Hajbi F; Chabrun E; Chanteloup E; Capdepont M; Razaire S; de Lédinghen V; Zerbib F
Aliment Pharmacol Ther; 2011 Aug; 34(4):462-9. PubMed ID: 21671970
[TBL] [Abstract][Full Text] [Related]
10. Impact of disease location on fecal calprotectin levels in Crohn's disease.
Gecse KB; Brandse JF; van Wilpe S; Löwenberg M; Ponsioen C; van den Brink G; D'Haens G
Scand J Gastroenterol; 2015 Jul; 50(7):841-7. PubMed ID: 25636819
[TBL] [Abstract][Full Text] [Related]
11. A prospective study of fecal calprotectin and lactoferrin as predictors of small bowel Crohn's disease in patients undergoing capsule endoscopy.
Bar-Gil Shitrit A; Koslowsky B; Livovsky DM; Shitrit D; Paz K; Adar T; Adler SN; Goldin E
Scand J Gastroenterol; 2017 Mar; 52(3):328-333. PubMed ID: 27841040
[TBL] [Abstract][Full Text] [Related]
12. Levels of Fecal Calprotectin Are Associated With the Severity of Postoperative Endoscopic Recurrence in Asymptomatic Patients With Crohn's Disease.
Boschetti G; Laidet M; Moussata D; Stefanescu C; Roblin X; Phelip G; Cotte E; Passot G; Francois Y; Drai J; Del Tedesco E; Bouhnik Y; Flourie B; Nancey S
Am J Gastroenterol; 2015 Jun; 110(6):865-72. PubMed ID: 25781366
[TBL] [Abstract][Full Text] [Related]
13. Fecal calprotectin as a biomarker of inflammatory lesions of the small bowel seen by videocapsule endoscopy.
Egea-Valenzuela J; Alberca-de-Las-Parras F; Carballo-Álvarez F
Rev Esp Enferm Dig; 2015 Apr; 107(4):211-4. PubMed ID: 25824919
[TBL] [Abstract][Full Text] [Related]
14. Fecal calprotectin and C-reactive protein are associated with positive findings in capsule endoscopy in suspected small bowel Crohn's disease.
Egea Valenzuela J; Pereñíguez López A; Pérez Fernández V; Alberca de Las Parras F; Carballo Álvarez F
Rev Esp Enferm Dig; 2016 Jul; 108(7):394-400. PubMed ID: 27312194
[TBL] [Abstract][Full Text] [Related]
15. Fecal calprotectin correlates more closely with the Simple Endoscopic Score for Crohn's disease (SES-CD) than CRP, blood leukocytes, and the CDAI.
Schoepfer AM; Beglinger C; Straumann A; Trummler M; Vavricka SR; Bruegger LE; Seibold F
Am J Gastroenterol; 2010 Jan; 105(1):162-9. PubMed ID: 19755969
[TBL] [Abstract][Full Text] [Related]
16. Fecal calprotectin for the prediction of small-bowel Crohn's disease by capsule endoscopy: a systematic review and meta-analysis.
Kopylov U; Yung DE; Engel T; Avni T; Battat R; Ben-Horin S; Plevris JN; Eliakim R; Koulaouzidis A
Eur J Gastroenterol Hepatol; 2016 Oct; 28(10):1137-44. PubMed ID: 27415156
[TBL] [Abstract][Full Text] [Related]
17. Elevated Faecal Calprotectin Levels are a Reliable Non-Invasive Screening Tool for Small Bowel Crohn's Disease in Patients Undergoing Capsule Endoscopy.
Yousuf H; Aleem U; Egan R; Maheshwari P; Mohamad J; McNamara D
Dig Dis; 2018; 36(3):202-208. PubMed ID: 29466790
[TBL] [Abstract][Full Text] [Related]
18. The utility of capsule endoscopy in patients with suspected Crohn's disease.
Tukey M; Pleskow D; Legnani P; Cheifetz AS; Moss AC
Am J Gastroenterol; 2009 Nov; 104(11):2734-9. PubMed ID: 19584828
[TBL] [Abstract][Full Text] [Related]
19. The diagnostic accuracy of faecal calprotectin and small bowel capsule endoscopy and their correlation in suspected isolated small bowel Crohn's disease.
Hale MF; Drew K; McAlindon ME; Sidhu R
Eur J Gastroenterol Hepatol; 2016 Oct; 28(10):1145-50. PubMed ID: 27384306
[TBL] [Abstract][Full Text] [Related]
20. Noninvasive markers in the assessment of intestinal inflammation in inflammatory bowel diseases: performance of fecal lactoferrin, calprotectin, and PMN-elastase, CRP, and clinical indices.
Langhorst J; Elsenbruch S; Koelzer J; Rueffer A; Michalsen A; Dobos GJ
Am J Gastroenterol; 2008 Jan; 103(1):162-9. PubMed ID: 17916108
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
